Craft

Jiangxi Fushine Pharmaceutical

Stock Price

¥11.4

2024-10-29

Market Capitalization

¥6.4 B

2024-10-29

Revenue

¥1.2 B

FY, 2024

Jiangxi Fushine Pharmaceutical Summary

Company Summary

Overview
Jiangxi Fushine Pharmaceutical (江西富祥药业股份有限公司) is a company that develops, manufactures, and sells active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It offers penicillin, carbapenem, tazobactam, sulbactam acid, and other products.
Type
Public
Status
Active
Founded
2002
Website
http://www.fushine.cn
Cybersecurity rating
Sectors

Table of Contents

Jiangxi Fushine Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2025)
¥252.7M
Gross profit (Q3, 2025)
¥4.3M
Net income (Q3, 2025)
(¥57.7M)
Cash (Q3, 2025)
¥632.7M
EBIT (Q3, 2025)
(¥49.5M)
Enterprise value
$7.7B

Footer menu